1:25-cv-01538 Mirum Pharmaceuticals, Inc. et al v. Sandoz Inc.
Case Summary
Mirum Pharmaceuticals, Inc. filed a lawsuit against Sandoz Inc. under docket number 25-cv-01538. The case details and substantive issues remain unclear as the only available court entry is an order marked 'SO ORDERED,' indicating a procedural ruling without further elaboration.
Stage
Active litigation
Timeline
3 events
Coverage
3 articles
Sources
1
Key Issues
- • Procedural order
- • Unclear substantive issues
- • Pharmaceutical litigation
Case Timeline
3 events1:25-cv-01538 Mirum Pharmaceuticals, Inc. et al v. Sandoz Inc.
In the case between Mirum Pharmaceuticals and Sandoz Inc., the parties submitted a general stipulation to the court. This means both sides agreed on certain facts or procedures to streamline the case. Such agreements help simplify the legal process and can speed up the resolution of the dispute.
1:25-cv-01537 Mirum Pharmaceuticals, Inc. et al v. Annora Pharma Private Limited et al
In the case involving Mirum Pharmaceuticals and Sandoz Inc., the parties submitted a general stipulation related to a separate but connected case against Annora Pharma Private Limited and others. This means both sides agreed on certain facts or procedures to streamline the legal process. Such agreements help avoid unnecessary disputes and speed up the resolution of the cases.
1:22-cv-01190 Biogen Inc. et al v. Sandoz Inc.
The court issued an official order in the case involving Biogen Inc. and Sandoz Inc., which is related to the ongoing litigation between Mirum Pharmaceuticals and Sandoz Inc. This order likely addresses procedural or substantive matters that impact how the case will proceed. Such orders help clarify the court's stance and guide the parties on next steps.
Press Coverage
1:25-cv-01538 Mirum Pharmaceuticals, Inc. et al v. Sandoz Inc.
Stipulation-General ( 23
1:25-cv-01537 Mirum Pharmaceuticals, Inc. et al v. Annora Pharma Private Limited et al
Stipulation-General ( 22